Journal Article Practice Guideline Epublish 16 citations
PubMed: 38206855 DOI: 10.15585/mmwr.mm7301a2
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024.
MMWR Morb Mortal Wkly Rep 73(1):6-10
Authors: A Patricia Wodi, Neil Murthy, Veronica V McNally, Matthew F Daley, Sybil Cineas
Abstract
At its October 2023 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States, 2024. The child and adolescent immunization schedule, which can be found on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules), is published annually to consolidate and summarize updates to ACIP recommendations on the vaccination of children and adolescents and to assist health care providers in implementing current ACIP recommendations. The 2024 immunization schedule includes several changes to the cover page, tables, notes, and appendix from the 2023 immunization schedule. In addition, the 2024 child and adolescent immunization schedule includes a new addendum section to summarize new or updated ACIP recommendations that will occur before the next annual update to the child and adolescent immunization schedule. Health care providers are advised to use the cover page, tables, notes, appendix, and addendum together to identify the recommended immunizations for patient populations.
MeSH
Mortality, Immunization, Vaccines, Aged, Appendix, Adolescent, Immunization Schedule, Morbidity, Child
Cited by
- Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection. Clin Chest Med, 2025
- Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines. Vaccine, 2024
- Tiered Clinician Vaccine Communication Strategy to Improve Childhood Vaccine Uptake: A Cluster Randomized Clinical Trial. JAMA Netw Open, 2025
- Characterization of HPV Vaccination Uptake by Birth Cohorts in a Healthcare System in Pennsylvania: A Post-COVID-19 Pandemic Historical Cohort Assessment. Cancer Control, 2025
- Vaccination uptake among post-treatment cancer survivors: A multi-vaccine scoping review. Vaccine, 2024
- Respiratory virus detections in children presenting to an Australian paediatric referral hospital pre-COVID-19 pandemic, January 2014 to December 2019. PLoS One, 2025
- Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024. Hum Vaccin Immunother, 2025
- Maternal Respiratory Syncytial Virus (RSV) Vaccination: Current Status and Comparison to Monoclonal Antibodies (mAbs) for RSV Prevention in Infants and Children. J Mother Child, 2025
- A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix Vaccine When Given to Healthy Infants at 3 and 12 Months of Age. Infect Dis Ther, 2025
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025. Diabetes Care, 2024
- Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia. Haematologica, 2025